Skip to main content

Animations

MJFF Publications

511 - 520 of 6078 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • OPEN
    Title: Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2024.2356490
    Citation Count: 5
  • OPEN
    Title: Exploring the role of underrepresented populations in polygenic risk scores for neurodegenerative disease risk prediction
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2024.1380860
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Profiling complex repeat expansions in RFC1 in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00723-0
    Citation Count: 2
  • OPEN
    Title: Association of body mass index with rapid eye movement sleep behavior disorder in Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1388131
    Citation Count: 1
  • OPEN
    Title: Epistatic Features and Machine Learning Improve Alzheimer’s Disease Risk Prediction Over Polygenic Risk Scores
    Journal Name: Journal of Alzheimer’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jad-230236
    Best OA location URL:
    Citation Count: 4
  • OPEN
    Title: Impulse control disorders and use of dopamine agonists in early onset Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1404904
    Citation Count: 4
  • OPEN
    Title: KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-60602-9
    Best OA location URL:
    Citation Count: 1
  • OPEN
    Title: A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13858
    Citation Count: 20
  • OPEN
    Title: Neither alpha-synuclein fibril strain nor host murine genotype influences seeding efficacy
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00679-1
    Citation Count: 0
  • OPEN
    Title: A person-centered approach to characterizing longitudinal ambulatory impairment in Parkinson's disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-62179-9
    Best OA location URL:
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.